Results 111 to 120 of about 6,030,066 (175)

Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals.

, 2010
OBJECTIVE: Studies investigating risk factors for visceral leishmaniasis (VL) on the Indian Subcontinent have shown contradictory results related to the role of domestic animals. In some studies having animals in or around the house was a risk factor, in
Singh, SP, Sundar, S, Singh, RP, Boelaert, M, Malaviya, P, Singh, R. P., Picado, A., Malaviya, P., Picado, A, Hasker, E, Hasker, E., Boelaert, M., Singh, S. P., Gidwani, K, Gidwani, K., Sundar, S.   +15 more
core   +1 more source

Cutaneous leishmaniasis, northern Afghanistan. [PDF]

, 2004
Reithinger, Richard, Kolaczinski, Jan, Aadil, Khoksar, Samad Hami, Jan Kolaczinski, Hami, Samad, Richard Reithinger, Khoksar Aadil   +7 more
core   +1 more source

INFLUENCE OF MICROBIOTA IN EXPERIMENTAL CUTANEOUS LEISHMANIASIS IN SWISS MICE

Revista do Instituto de Medicina Tropical de São Paulo, 1999
Infection of Swiss/NIH mice with Leishmania major was compared with infection in isogenic resistant C57BL/6 and susceptible BALB/c mice. Swiss/NIH mice showed self-controlled lesions in the injected foot pad. The production of high levels of interferon-g
OLIVEIRA Marcia Rosa de, TAFURI Wagner Luis, NICOLI Jacques Robert, VIEIRA Enio Cardillo, MELO Maria Norma, VIEIRA Leda Quercia   +5 more
doaj  

Declining Visceral Leishmaniasis in Malta [PDF]

, 2008
Aims: To study visceral leishmaniasis (VL) trends in Malta. Methods: Analysis of epidemiological and clinical trends, a veterinary questionnaire and questioning a canine laboratory testing facility.
Grech, Victor E., Vella, Cecil
core  

A Human Monoclonal Antibody Targeting α-Gal Ameliorates Experimental Cutaneous Leishmaniasis. [PDF]

J Infect Dis
Cho H, Paun A, Seo Y, Lee SH, Traver M, Zhao M, Skinner J, Tan J, Sacks DL, Crompton PD.   +9 more
europepmc   +1 more source

Nanoformulated <i>Walterinnesia aegyptia</i> Venom Enhances Therapeutic Outcomes in Experimental Cutaneous Leishmaniasis: A Comparative Study of Hyaluronic Acid and Silver Nanoparticles. [PDF]

Nanomaterials (Basel)
Al-Aqil A, Al Nasr IS, Hakami H, Abou El Fadl F, Wang C, Al-Shammari M, Alotaibi S, Alotaibi S, Al-Qurashi A, Al-Rashid H, Al-Olayan E.   +10 more
europepmc   +1 more source

CD4+ T cell subsets in experimental cutaneous leishmaniasis

Memorias do Instituto Oswaldo Cruz, 1988
Phillip Scott, Patricia Natovitz, Robert L. Coffman, Edward Pearce, Alan Sher   +4 more
doaj   +1 more source

Topical AuNPs-Cys-Sm29 gel modulates the course of lesion development in experimental cutaneous leishmaniasis. [PDF]

PLoS Negl Trop Dis
Viana SM, Cardoso L, Borba PB, Carvalho LP, Moreira J, Mambelli F, Oliveira SC, Carvalho EM, de Oliveira CI.   +8 more
europepmc   +1 more source

Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis. [PDF]

Antimicrob Agents Chemother, 2017
Wijnant GJ, Van Bocxlaer K, Yardley V, Murdan S, Croft SL.   +4 more
europepmc   +1 more source

The effects of host-vector relationships and density dependence on the epidemiology of visceral leishmaniasis [PDF]

In Latin America, visceral leishmaniasis (VL) is caused by infection with Leishmania infantum, an endemic but lethal parasite transmitted by Lutzomyia longipalpis sandflies.
Dilger, Erin
core